榮泰健康(603579.SH):擬舉辦“榮泰健康股東回饋特別活動”
格隆匯7月24日丨榮泰健康(603579.SH)公佈,為了回饋股東朋友長期以來對公司的支持與厚愛,表達對投資者的感恩,同時讓廣大股東深入瞭解體驗公司的產品與服務,提高對公司業務與價值的理解與認可,公司將舉辦“榮泰健康股東回饋特別活動”。為了回饋股東朋友長期以來對公司的支持與厚愛,公司針對股東開展“榮泰健康股東回饋特別活動”。本次活動期間,公司股東均可按股東專屬折扣購入公司指定產品。本次活動的股東範圍:2025年7月28日至2025年8月18日期間,在中國證券登記結算有限責任公司上海分公司登記在冊的公司全體股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.